Funded Projects

Explore our currently funded projects. You may search with all three fields, then focus your results by applying any of the dropdown filters. After customizing your search, you may download results and even save your specific search for later.

Reset
Project # Project Title Research Focus Area Research Program Administering IC Institution(s) Investigator(s) Location(s) Year Awarded
3UG1DA013035-17S7 Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy New Strategies to Prevent and Treat Opioid Addiction Optimizing the Duration, Retention, and Discontinuation of Medication Treatment for Opioid Use Disorder NIDA New York University School of Medicine ROTROSEN, JOHN P New York, NY 2019
NOFO Title: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
NOFO Number: PA-18-591
Summary:

This study will (1) test pharmacologic and behavioral strategies to improve OUD pharmacotherapy treatment retention and to improve outcomes among patients who have been successfully stabilized on OUD medications and want to stop medication and (2) identify predictors of successful outcome and develop a stage model of relapse risk.
3UG1DA013035-18S5 Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy New Strategies to Prevent and Treat Opioid Addiction Optimizing the Duration, Retention, and Discontinuation of Medication Treatment for Opioid Use Disorder NIDA New York University School of Medicine ROTROSEN, JOHN P New York, NY 2019
NOFO Title: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
NOFO Number: PA-18-591
Summary:

This study will (1) test pharmacologic and behavioral strategies to improve OUD pharmacotherapy treatment retention and to improve outcomes among patients who have been successfully stabilized on OUD medications and want to stop medication and (2) identify predictors of successful outcome and develop a stage model of relapse risk.
3UG1DA015831-17S5 Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy New Strategies to Prevent and Treat Opioid Addiction Optimizing the Duration, Retention, and Discontinuation of Medication Treatment for Opioid Use Disorder NIDA McLean Hospital WEISS, ROGER D Belmont, MA 2019
NOFO Title: The National Drug Abuse Treatment Clinical Trials Network (UG1)
NOFO Number: RFA-DA-15-008
Summary:

This study will (1) test pharmacologic and behavioral strategies to improve OUD pharmacotherapy treatment retention and to improve outcomes among patients who have been successfully stabilized on OUD medications and want to stop medication and (2) identify predictors of successful outcome and develop a stage model of relapse risk.
3UG1DA015831-18S8 Optimizing Retention, Duration, and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy New Strategies to Prevent and Treat Opioid Addiction Optimizing the Duration, Retention, and Discontinuation of Medication Treatment for Opioid Use Disorder NIDA McLean Hospital Weiss, Roger Belmont, MA 2019
NOFO Title: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
NOFO Number: PA-18-591
Summary:

This study will (1) test pharmacologic and behavioral strategies to improve OUD pharmacotherapy treatment retention and to improve outcomes among patients who have been successfully stabilized on OUD medications and want to stop medication and (2) identify predictors of successful outcome and develop a stage model of relapse risk.
75N95019D00013-P00002-759502000002-1 Optimizing Retention, Duration, and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy New Strategies to Prevent and Treat Opioid Addiction Optimizing the Duration, Retention, and Discontinuation of Medication Treatment for Opioid Use Disorder NIDA Emmes Corportation VanVeldhuisen, Paul Rockville, MD 2019
NOFO Number:
Summary:

This study will (1) test pharmacologic and behavioral strategies to improve OUD pharmacotherapy treatment retention and to improve outcomes among patients who have been successfully stabilized on OUD medications and want to stop medication and (2) identify predictors of successful outcome and develop a stage model of relapse risk.